VIA
NTBL

Vident Investment Advisory’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Vident Investment Advisory’s Portfolio NTBL Stock Details NTBL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-656
Closed -$46K – 1119
2021
Q1 		$46K Buy
656
+219
+50% +$17.1K ﹤0.01% 987
2020
Q4 		$29K Hold
437
– – ﹤0.01% 893
2020
Q3 		$19K Buy
+437
New +$19.3K ﹤0.01% 865

Other funds holding NTBL

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Vident Investment Advisory's NTBL Position: Q2 2021 in Review

Vident Investment Advisory sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q2 2021, closing a stake of 656 shares — an estimated $46K sold.

Vident Investment Advisory first reported a position in NTBL in Q3 2020 and held it in 3 quarters. The position peaked at $46K in Q1 2021. 23 funds tracked by Wall St. Rank hold NTBL as of Q2 2021.

  • Vident Investment Advisory reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • Vident Investment Advisory sold 656 Notable Labs, Ltd. Ordinary Shares shares in Q2 2021, an estimated $46K.
  • Vident Investment Advisory first reported a position in Notable Labs, Ltd. Ordinary Shares in Q3 2020 and held it in 3 quarters.
  • Vident Investment Advisory's Notable Labs, Ltd. Ordinary Shares position peaked at $46K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q2 2021.

Based on Vident Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.